During the past decade, Hôpital de Bois Guillaume conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital de Bois Guillaume" #1 sponsor was "University Hospital, Tours" with 3 trials, followed by "Centre Hospitalier Universitaire, Amiens" with 2 trials sponsored, "Ipsen" with 2 trials sponsored, "Rennes University Hospital" with 2 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital de Bois Guillaume" #1 collaborator was "Roche Pharma AG" with 4 trials as a collaborator, "Assistance Publique Hopitaux De Marseille" with 1 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Centre Hospitalier Universitaire de Besancon" with 1 trials as a collaborator and "Centre Hospitalier Universitaire de Nice" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital de Bois Guillaume" are "Acromegaly" (2 trials), "Renal Transplantation" (2 trials), "Rheumatoid Arthritis" (2 trials), "Adrenal Gland Neoplasms" (1 trials) and "Anaemia" (1 trials). Many other conditions were trialed in "Hôpital de Bois Guillaume" in a lesser frequency.

Most popular intervention types in "Hôpital de Bois Guillaume" are "Drug" (10 trials), "Biological" (2 trials), "Other" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "MabThera" (2 trials), "BiPAP - A40" (1 trials), "BiPAP - ST" (1 trials), "Dual-agent therapy or docetaxel alone or best supportive care" (1 trials) and "ERYPO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital de Bois Guillaume" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Hôpital de Bois Guillaume". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Hôpital de Bois Guillaume, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital de Bois Guillaume, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".